Last reviewed · How we verify
diethylamino hydroxybenzoyl hexyl benzoate
diethylamino hydroxybenzoyl hexyl benzoate is a drug. It is currently FDA-approved.
At a glance
| Generic name | diethylamino hydroxybenzoyl hexyl benzoate |
|---|---|
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- diethylamino hydroxybenzoyl hexyl benzoate CI brief — competitive landscape report
- diethylamino hydroxybenzoyl hexyl benzoate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about diethylamino hydroxybenzoyl hexyl benzoate
What is diethylamino hydroxybenzoyl hexyl benzoate?
diethylamino hydroxybenzoyl hexyl benzoate is a pharmaceutical drug.
What development phase is diethylamino hydroxybenzoyl hexyl benzoate in?
diethylamino hydroxybenzoyl hexyl benzoate is FDA-approved (marketed).
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
- Compare: diethylamino hydroxybenzoyl hexyl benzoate vs similar drugs
- Pricing: diethylamino hydroxybenzoyl hexyl benzoate cost, discount & access